AZGP1 and chronic kidney disease: We further showed that subcutaneous white adipose tissue biopsies from patients with end-stage renal disease exhibited a higher content of ZAG (5.7 folds) than age-matched controls [33], raising the hypothesis that deregulation of ZAG secretion could also contribute to the increased plasma ZAG concentration reported ESRD patients.